Maravai Lifesciences Holdings's total assets for Q4 2024 were $1.01B, a decrease of -21.12% from the previous quarter. MRVI total liabilities were $431.04M for the fiscal quarter, a -35.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.